Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORENTRA: Omega-3 Fatty Acids in Renal Transplant Recipients
NCT01744067Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in kidney transplantation comparing Omega-3 fatty acids with Placebo (2 arms). Primary endpoint: Glomerular filtration rate at 44 weeks. Started Nov 2013; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01744067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01744067.